Horizon Therapeutics Public Ltd Co
HZNPDelisted Oct 6, 2023- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001492426
Horizon Therapeutics Public Ltd Co was delisted on Oct 6, 2023; its insiders filed their last Form 4 on Oct 6, 2023; 483 institutions reported holding it in 13F filings for Q3 2023, worth $24.8B in total; Soros Fund Management was the only superinvestor holding it.
Key figures
- Market cap
- –
- Not available
- Insider buys
- 0
- Open market, last 90 days
- Insider sells
- 0
- Open market, last 90 days
- 13F holders
- 483
- Q3 2023, −31 vs. previous quarter
- 13F value
- $24.8B
- Reported value at the end of Q3 2023
- Superinvestors holding
- 1
- At the end of Q3 2023
Financials
See financial statementsFrom SEC filings, in USD.
- Revenue, FY2022
- $3.63B
- +12.5% year over year
- Net income, FY2022
- $521.5M
- −2.4% year over year
- Free cash flow, FY2022
- $1.19B
- +24.5% year over year
- Revenue, Q2 FY2023
- $945.0M
- +7.8% year over year
Revenue flow, FY2022
Green is profit; orange is costs, expenses and taxes. Percentages are shares of revenue.
Superinvestors holding HZNP, Q3 2023
Go to the superinvestors tab1 superinvestor reports holding Horizon Therapeutics Public Ltd Co on Form 13F. Percentages are the stock's share of each portfolio.
Soros Fund Management
George Soros
7.8%
Horizon Therapeutics Public Ltd Co's share of the portfolio
- Shares
- 3,289,584
- Value
- $380.6M
Latest insider trades
See all insider tradesOpen-market purchases and sales by Horizon Therapeutics Public Ltd Co insiders from Form 4, newest first.
| Filed (ET) | Trade date | Filing delay | Insider | Transaction | Shares | Avg price | Value | Holding change | Flags |
|---|---|---|---|---|---|---|---|---|---|
| Jan 18, 2023 (view filing) | Jan 17 | 1 day | Pasternak AndyEVP, Chief Strategy Officer | SSale | −27.1K | $113.03 | −$3.07M | −32.5%56.3K after | |
| Jan 17, 2023 (view filing) | Jan 13 | 4 days | Cox AaronEVP, Chief Financial Officer | SSale | −36.1K | $113.17 | −$4.09M | −99.2%277 after | |
| Jan 12, 2023 (view filing) | Jan 10-11 | 2 days | Sherman Jeffrey WEVP and Chief Medical Officer | SSale | −6.74K | $113.08 | −$761.7K | −15.7%36.2K after | 2 lots |
| Jan 6, 2023 (view filing) | Jan 6 | Same day | Sherman Jeffrey WEVP and Chief Medical Officer | SSale | −5.19K | $113.29 | −$587.6K | −9.5%49.3K after | |
| Dec 14, 2022 (view filing) | Dec 13 | 1 day | Pasternak AndyEVP, Chief Strategy Officer | SSale | −30.2K | $112.61 | −$3.40M | −47.0%34.0K after | 2 lots |
| Dec 13, 2022 (view filing) | Dec 12 | 1 day | Sherman Jeffrey WEVP and Chief Medical Officer | SSale | −28.4K | $111.45 | −$3.16M | −25.1%84.4K after | 2 lots |
| Aug 8, 2022 (view filing) | Aug 4 | 4 days | Clayton Sean M.EVP, General Counsel | PPurchase | +745 | $66.67 | +$49.7K | New position745 after | |
| Jul 29, 2022 (view filing) | Jul 29 | Same day | Pasternak AndyEVP and Chief Business Officer | SSale | −4.85K | $82.57 | −$400.5K | −12.5%34.0K after | 2 lots |
| Jul 20, 2022 (view filing) | Jul 19-20 | 1 day | Thompson Elizabeth H.Z.EVP, Research & Development | SSale | −6.01K | $85.00 | −$510.6K | −46.3%6.97K after | 3 lots |
| Jul 11, 2022 (view filing) | Jul 7 | 4 days | Thompson Elizabeth H.Z.EVP, Research & Development | SSale | −82 | $85.01 | −$6.97K | −0.6%13.0K after |
Top 10 13F holders, Q3 2023
See all 483 holdersThe largest institutional positions in Horizon Therapeutics Public Ltd Co at the end of Q3 2023; share changes are against Q2 2023.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| Vanguard Group Inc | 21,587,441 | $2.50B | 0.06% | +42,917+0.2% | Added |
| Pentwater Capital Management LP | 15,552,000 | $1.80B | 17.32% | +2,825,100+22.2% | Added |
| BlackRock Inc. | 14,871,176 | $1.72B | 0.05% | −32,505−0.2% | Reduced |
| HBK Investments L P | 7,978,967 | $923.1M | 20.48% | +1,928,967+31.9% | Added |
| UBS Oconnor LLC | 7,664,245 | $886.7M | 15.86% | +3,332,978+77.0% | Added |
| Norges Bank | 7,105,064 | $822.0M | 0.17% | +1,547,758+27.9% | Added |
| Avoro Capital Advisors LLC | 7,000,000 | $809.8M | 12.63% | 00.0% | Unchanged |
| Farallon Capital Management, L.L.C. | 6,656,823 | $770.1M | 4.35% | −265,000−3.8% | Reduced |
| State Street Corp | 5,233,927 | $605.5M | 0.03% | −40,125−0.8% | Reduced |
| JPMorgan Chase & Co | 5,042,293 | $583.3M | 0.07% | −448,947−8.2% | Reduced |
Politician trades
All politician trades in HZNP2 members of Congress reported 2 trades in Horizon Therapeutics Public Ltd Co since 2020. Newest filings:
| Filed | Politician | Type | Amount |
|---|---|---|---|
| Aug 14, 2024 | Greg Landsman House · OH | Sell | $1K-$15K |
| Feb 24, 2023 | Daniel S. Goldman House · NY | Sell | $15K-$50K |

House · OH · Aug 14, 2024
Sell$1K-$15K

House · NY · Feb 24, 2023
Sell$15K-$50K